Article metrics

Download PDFPDF

742 Phase 1/2 study of the bispecific 4–1BB and PD-L1 antibody INBRX-105 alone and in combination with pembrolizumab in select solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023372028
Dec 2023180025
Jan 20248708
Feb 20246606
Mar 2024278024
Apr 202413807
May 2024172010
Jun 202410907
Jul 202416009
Aug 2024156013
Sep 2024128013
Oct 2024200013
Nov 2024150014
Dec 2024118013
Jan 2025201026
Feb 202536016
Mar 20250014
Apr 20250012
May 2025009
Jun 2025008
Total25510275